利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

48 条记录 (耗时 0.016 秒)

    ULTRAVIOLET ABSORBENT AND POLYMER MATERIAL CONTAINING THE SAME
    2.
    发明申请
    ULTRAVIOLET ABSORBENT AND POLYMER MATERIAL CONTAINING THE SAME 审中-公开
    超紫外线吸收剂和聚合物材料

    公开(公告)号：US20100010123A1

    公开(公告)日：2010-01-14

    申请号：US12499493

    申请日：2009-07-08

    申请人： Yoshihiko Fujie ,  Takashi Hoshimiya ,  Hisashi Mikoshiba

    发明人： Yoshihiko Fujie ,  Takashi Hoshimiya ,  Hisashi Mikoshiba

    IPC分类号： C08K5/3445 ,  C07D231/34

    CPC分类号： C07D231/34 ,  C07D231/36 ,  C08K5/005 ,  C08K5/3445

    摘要： An ultraviolet absorbent, containing a compound represented by formula (1) or (2); and a polymer material containing the ultraviolet absorbent: wherein R11, R12 and R14 each independently represent a monovalent substituent; R13 represents a hydrogen atom or a substituent having a Hammett substituent constant σp of −0.35 or more; and n represents an integer of 0 to 4; and wherein R21 represents a substituted or unsubstituted alkyl group having 1 to 18 carbon atoms, or a substituted or unsubstituted phenyl group; R22 represents a substituted or unsubstituted alkyl group having 1 to 18 carbon atoms; R23 represents a hydrogen atom or a substituent having a Hammett substituent constant σp of −0.35 or more; R24 represents a monovalent substituent; and m represents an integer of 0 to 4.

    摘要翻译： 含有式（1）或（2）表示的化合物的紫外线吸收剂; 和含有紫外线吸收剂的高分子材料，其中R11，R12和R14各自独立地表示一价取代基; R13表示氢原子或哈米特取代基常数sigmap为-0.35以上的取代基; n表示0〜4的整数。 并且其中R 21表示取代或未取代的具有1至18个碳原子的烷基，或取代或未取代的苯基; R 22表示取代或未取代的碳原子数1〜18的烷基。 R23表示氢原子或具有-355以上的哈米特取代基常数sigmap的取代基; R 24表示一价取代基; m表示0〜4的整数。

    Transient pro-drug forms of phenylbutazone
    6.
    发明授权
    Transient pro-drug forms of phenylbutazone 失效
    苯乙酮的瞬时药物形式

    公开(公告)号：US4117232A

    公开(公告)日：1978-09-26

    申请号：US777074

    申请日：1977-03-14

    申请人： Nicolae S. Bodor ,  Kenneth B. Sloan

    发明人： Nicolae S. Bodor ,  Kenneth B. Sloan

    IPC分类号： C07D231/34

    CPC分类号： C07D231/34

    摘要： Novel, transient pro-drug forms of the anti-inflammatories phenylbutazone and oxyphenbutazone are disclosed, the same having the structural formulae: ##STR1## wherein R is a member selected from the group consisting of C.sub.1 -C.sub.2 alkylsulfonyl, phenylsulfonyl, p-tolylsulfonyl and naphthylsulfonyl, and ##STR2## wherein X and Y each represent a member selected from the group consisting of a hydrogen atom and ##STR3## with the proviso that either X or Y is a hydrogen atom, R.sub.1 is selected from the group consisting of C.sub.1 -C.sub.2 alkylsulfonyl, phenylsulfonyl, p-tolylsulfonyl and naphthylsulfonyl, and R.sub.2 is selected from the group consisting of straight or branched chain C.sub.1 -C.sub.5 alkyl and phenyl.

    摘要翻译： 公开了化合物1,2-二苯基-3,5-二氟乙酰氧基-4-丁基-5-羟基-3-吡唑啉作为制备所选择的保泰松酮衍生物的中间体。